7 Feb 2026Open access
The Role of Medicinal Herbs and Phytochemicals in Cancer Management: A ReviewMiddle Eastern Cancer and Oncology Journal, Ginger and Zingiberaceae research
Active, last published 2026
In pharmaceutical economics and policy
Leila
Achour
Scholar“Research focused on Pharmaceutical Economics and Policy and adjacent fields.”
Tunis El Manar University
Tunisia
Claim Your ProfileTunisia3
H-index
25
Citations
Leila has not officially claimed their profile. If you are Leila, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
01 · About the work
What I study
eila Achour is a researcher working on Pharmaceutical Economics and Policy. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Leila's work has been cited 25 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Pharmaceutical Economics and Policy×12Health Systems, Economic Evaluations, Quality of Life×8Hematopoietic Stem Cell Transplantation×3Acute Myeloid Leukemia Research×2Acute Lymphoblastic Leukemia research×2
04 · Where I am
Affiliations
CurrentlyTunis University, Tunisia
Research themes (UN SDGs)
05 · Selected work
Recent publications
21 works1 Sept 2025Open access
Cost Assessment of Pediatric Haploidentical Hematopoietic Stem Cell TransplantationClinicoEconomics and Outcomes Research, Hematopoietic Stem Cell Transplantation
11 Aug 2025Open access
Managed Entry Agreements for Pharmaceutical Products in Three Maghreb Countries: Payer and Supplier PerspectivesJournal of Market Access & Health Policy, Pharmaceutical Economics and Policy
Are you Leila?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required